Gilead Sciences to Present at Upcoming Investor Conference

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference:

• J.P. Morgan Healthcare Conference on Monday, January 12, 2026 beginning at 11:15 a.m. Pacific Time

The live webcast can be accessed at investors.gilead.com and the replay will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251222000246/en/

Jacquie Ross, Investors
[email protected]

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• GMO GlobalSign Expands TLS Connect by GMO Availability, Bringing CLM Automation to Small and Medium Enterprises in APAC and the Middle East
• Seasonal HVAC Tune-Up Initiative Launches in Durham Region
• TNS Appoints Michael Johnson as Global Managing Director, Payments Market Business